Medlive Technology Co., Ltd. (2192.HK)
2192.HK Stock Price Chart
Explore Medlive Technology Co., Ltd. interactive price chart. Choose custom timeframes to analyze 2192.HK price movements and trends.
2192.HK Company Profile
Discover essential business fundamentals and corporate details for Medlive Technology Co., Ltd. (2192.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
15 Jul 2021
Employees
747.00
Website
https://www.medlive.cnCEO
Liping Tian
Description
Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, protocol design, medical monitoring, patient recruitment, and supporting system, as well as digital market research, electronic data capture, real-world studies, and application software development services. The company's medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies. Its intelligent patient management solution provides chronic disease management services, comprising online patient consultation, prescription services, and patient management through Internet hospital; and condition-specific patient education services, which includes content development, application software development, and other related services. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. Medlive Technology Co., Ltd. was founded in 1996 and is headquartered in Beijing, China.
2192.HK Financial Timeline
Browse a chronological timeline of Medlive Technology Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Mar 2026
Dividend declared on 5 Sept 2025
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend will be paid on 25 Sept 2025.
Earnings released on 25 Aug 2025
EPS came in at $0.23 , while revenue for the quarter reached $341.93M .
Dividend declared on 12 May 2025
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 6 Jun 2025.
Earnings released on 24 Mar 2025
EPS came in at $0.24 , while revenue for the quarter reached $335.11M .
Dividend declared on 22 Oct 2024
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 18 Nov 2024.
Earnings released on 27 Aug 2024
EPS came in at $0.21 , while revenue for the quarter reached $261.43M .
Dividend declared on 28 May 2024
A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 24 Jun 2024.
Earnings released on 25 Mar 2024
EPS came in at $0.22 surpassing the estimated $0.19 by +16.10%, while revenue for the quarter reached $263.97M , missing expectations by -52.52%.
Dividend declared on 7 Nov 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 4 Dec 2023.
Earnings released on 29 Aug 2023
EPS came in at $0.14 surpassing the estimated $0.10 by +48.88%, while revenue for the quarter reached $187.63M , beating expectations by +0.13%.
Dividend declared on 13 Jun 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 10 Jul 2023.
Earnings released on 24 Mar 2023
EPS came in at $0.14 surpassing the estimated $0.11 by +23.85%, while revenue for the quarter reached $207.40M , missing expectations by -54.51%.
Earnings released on 25 Aug 2022
EPS came in at $0.04 falling short of the estimated $0.07 by -39.19%, while revenue for the quarter reached $154.47M , missing expectations by -1.03%.
Dividend declared on 14 Jun 2022
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 11 Jul 2022.
Earnings released on 24 Mar 2022
EPS came in at $0.04 falling short of the estimated $0.12 by -71.08%, while revenue for the quarter reached $188.28M , beating expectations by +0.43%.
Earnings released on 27 Aug 2021
EPS came in at $0.04 falling short of the estimated $0.14 by -70.16%, while revenue for the quarter reached $156.88M , beating expectations by +3.70%.
Earnings released on 31 Dec 2020
EPS came in at $0.11 , while revenue for the quarter reached $148.11M .
2192.HK Stock Performance
Access detailed 2192.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.